Evidence map›Paper›PMID 33676435›Full record

ArticleBMC cancer2021

Validating a generic cancer consumer quality index in eight European countries, patient reported experiences and the influence of cultural differences.

A Wind, E D Hartman, R R J P Van Eekeren, R P W F Wijn, J Halámková, J Mattson, S Siesling, W H van Harten

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

A Wind *Rijnstate Hospital, Arnhem, The Netherlands. ankewind@gmail.com.ORCID http://orcid.org/0000-0002-9368-2519
E D Hartman *Rijnstate Hospital, Arnhem, The Netherlands.
R R J P Van EekerenRijnstate Hospital, Arnhem, The Netherlands.
R P W F WijnDepartement of Urology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
J HalámkováDepartment of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
J MattsonHelsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
S SieslingDepartment of Health Technology and Services Research, technical Medical Centre, Faculty of behavioural, management and social sciences (BMS), University of Twente, Enschede, The Netherlands.
W H van HartenRijnstate Hospital, Arnhem, The Netherlands.
Rijnstate Hospital · NLHelsinki University Hospital · FIJeroen Bosch Ziekenhuis · NLMasaryk University · CZNetherlands Comprehensive Cancer Organisation · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTaking patient centeredness into account is important in healthcare. The European Cancer Consumer Quality Index (ECCQI) is a validated tool for international benchmarking of patient experiences and satisfaction. This study aimed to further validate the ECCQI in larger and more uniform groups of high volume tumours such as breast and prostate cancer. A second objective was the verification of the influence of cultural factors of the country to determine its possible use in international benchmarking.

methodsData from two survey studies in eight European countries were combined. Socio-demographic correlations were analysed with Kruskall-Wallis and Mann-Whitney tests. Cronbach's alpha was calculated to validate internal consistency. Influences of masculinity (MAS), power distance (PD) and uncertainty avoidance (UA) were determined by linear regression analysis in a general model and subgroup models.

resultsA total of 1322 surveys were included in the analysis (1093 breast- and 348 prostate cancer patients). Cronbach's alpha was good (α ≥ 0.7) or acceptable (0.5 ≤ α ≤ 0.7) in 8 out of 9 questionnaire categories, except in the category 'Safety' (α = 0.305). Overall ECCQI scores ranged from 22.1 to 25.1 between countries on a 1-35 scale (categories had a 1-4 scale). In certain subcategories such as 'Organisation' (range 2.2 vs 3.0) and 'Supervision & Support' (range 3.0 vs 3.8) a large difference was observed between countries. Differences in 'Overall opinion' were however small: mean scores of 3.7 vs 3.9, whereas median scores were all the maximum of 4.0. Power distance was positively associated with higher patient satisfaction scores whereas Uncertainty avoidance was negatively associated with these scores. Masculinity was only associated with patient satisfaction scores in lower educated patients. We found the highest impact of culture on overall scores in Hungary and Portugal and the lowest in Romania.

conclusionsThe ECCQI shows high internal consistency in all categories except 'Safety'. Especially in separate categories and overall ECCQI scores the questionnaire showed discriminative value. This study showed a positive correlation of power distance and a negative correlation for uncertainty avoidance in some countries. When using the ECCQI for international benchmarking these two dimensions of culture should be taken into account.

Indexed as

Cross-Cultural ComparisonPatient Reported Outcome MeasuresAdolescentAdultAgedBenchmarkingBreast NeoplasmsCancer SurvivorsEuropeFemaleHumansMaleMiddle AgedPatient SafetyPatient SatisfactionProstatic NeoplasmsCancer careConsumer qualityCultural dimensionsPatient satisfaction

Identifiers

PMID33676435
PMCPMC7937284
OpenAlexW3135066768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.